Reta test = ZERO?!

[Mel57]

Has anyone here had an adverse reaction to a peptide? I'm curious about the potential for contamination.

 

[Nat_80]

I had a buddy who said he got some bad stuff once. He felt like he had the flu almost instantly. I stay away from that stuff now.

 

[Caffeine_Queen]

Some testing has actually confirmed the zero-pep issue on certain kits, and a few folks here have noticed efficacy problems. A test group is being set up to get concrete answers soon.

 

[month3-here36]

Zero side effects except heartburn, always had that anyway. Constipation early on, fixed with magnesium. Full physical recent, tests amazing. Palpitations pre-tirz from carrying extra weight. Check: 80 pounds off.

 

[RunGuy963]

Zero active ingredient from a group purchase is a serious find. Worth flagging in the vendor thread so others can hold off while more tests come in. This is exactly what the community testing groups are for.

 

[Pip_69]

Endos testing started because vendor COAs rarely cover it - the community noticed the gap and started filling it themselves.

 

[Health_Better]

Testing history across multiple lots is what matters. Single results are data; pattern of results is signal.

 

[under-construction]

Testing a second vial from the same kit is the right first step. If that one also comes back empty, that's a clear batch issue.

 

[tirzepatide-convert]

Quest ultra-sensitive E2 is the right assay for hormonal tracking.

 

[Nerdy_Go]

The zero result on a batch from a group purchase is the scenario everyone wants to avoid. If multiple people are testing from the same lot and all zeroing out, it is the source not the testing. One confirmation test is worth doing before writing it off. If the lot is dead, the group purchase organizers need to know.

 

[Geeky_Babe392]

Zero on testing is a vendor quality failure, not a storage issue - freeze/thaw is a separate variable from a batch that was never active to begin with. Group purchases amplify the risk when testing coverage is thin.

 

[PeptidePro]

The zero-ingredient batch report is the supply-chain risk that group purchases carry more than established vendors - the test result is what matters here. For post-op cardiac situations, the RHR increase from Reta's glucagon component is the real factor to evaluate: Reta drives more glucagon signaling than Tirz or sema, and that cardiac load in the months after surgery needs a cardiology clearance conversation. If your dad is cleared for moderate aerobic exertion, the RHR bump is likely manageable. If not, Tirz is the lower glucagon-load option for the same metabolic benefit.

 

[Sema-Siren]

Zero active ingredient in a tested batch is the worst result but also the most actionable - it removes any ambiguity about whether the issue is dosing or sourcing, and points the group buy organizer directly at the vendor.